<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">The primary antibodies used in this study were as follows: ATF6 (Beyotime, 24,169–1-AP), phospho-IRE1 (Abcam, ab48187), BIP (Beyotime, AB310), phospho-elF2α (Cell Signaling Technology, #9721), total elf2α (Cell Signaling Technology, #9722), XBP1 (Abcam, ab37152), β-actin (Beyotime, AF0003), and ZIKV envelope protein (BioFront Technologies, BF-1176-56). All antibodies were diluted in accordance with the manufacturer’s protocol.</p>
